Randomised clinical trials: linaclotide phase 3 studies in <scp>IBS</scp> ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

2012123 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov (identifiers: NCT00948818 and NCT00938717).

Good health and well-being

Published in: Alimentary Pharmacology & Therapeutics

Volume 37, Issue 1, pp. 49-61

Field-Weighted Citation Impact: 10.66